Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Acquisitions Goodwill, Acquired During Period Statistical Measurement [Domain] Statistical Measurement [Domain] Repayment of term loan borrowings Repayments of Long-term Debt Repayments of Long-Term Debt Remaining authorized amount Share Repurchase Program, Remaining Authorized, Amount Cover [Abstract] Cover [Abstract] Net Change in Cash and Cash Equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Derivative, blended fixed interest rate Derivative, Blended Fixed Interest Rate Derivative, Blended Fixed Interest Rate In-process research and development In Process Research and Development [Member] Non-cash transfers from inventory to property, plant and equipment for Haemonetics equipment Transfers from Inventory to Fixed Assets Transfers from inventory to fixed assets. Inventory reserve adjustment Benefit (Provision) For Losses On Inventory Benefit (Provision) For Losses On Inventory Other current liabilities Other Liabilities, Current Trading Symbol Trading Symbol Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] All Trading Arrangements All Trading Arrangements [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Derivative Assets Derivative Asset, Subject to Master Netting Arrangement, before Offset Non-NEOs Non-NEOs [Member] Schedule of Earnings Per Share Reconciliation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Derivative [Line Items] Derivative [Line Items] Repurchase of convertible senior notes Decrease For Redemption Of Convertible Senior Notes Decrease For Redemption Of Convertible Senior Notes Accounts receivable, allowance Accounts Receivable, Allowance for Credit Loss, Current Purchase accounting adjustments Goodwill, Measurement Period Adjustment Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Change in accounts receivable Increase (Decrease) in Accounts Receivable Derivative [Table] Derivative [Table] Income Tax Contingency [Table] Income Tax Contingency [Table] BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Issuance of restricted stock, net of cancellations (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Hedging Relationship [Domain] Hedging Relationship [Domain] Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Land Land [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Award Timing Disclosures [Line Items] Debt instrument, redemption price, percentage of previous closing price Debt Instrument, Redemption Price, Percentage of Previous Closing Price Debt Instrument, Redemption Price, Percentage of Previous Closing Price Change in other assets and other liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Investment, Name [Domain] Investment, Name [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Fiscal 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Three Goodwill [Line Items] Goodwill [Line Items] LEASES Lessee, Operating Leases [Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Cash Flow Hedging Cash Flow Hedging [Member] Investments, All Other Investments [Abstract] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] United States UNITED STATES Net effect of common stock equivalents (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Other long-term assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Leases [Abstract] Leases [Abstract] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] Accounting Standards Update and Change in Accounting Principle [Abstract] Payments for legal settlements Payments for Legal Settlements Operating Segments Operating Segments [Member] Discrete tax benefit (expense) Tax Adjustments, Settlements, and Unusual Provisions Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Proceeds from issuance of convertible notes Proceeds from Convertible Debt Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Patents and other Patents [Member] Cash Flows from Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Equity Components [Axis] Equity Components [Axis] Award Timing Method Award Timing Method [Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trade names Trade names Trade Names [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Share Repurchase Program [Table] Share Repurchase Program [Table] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Number of Interest Rate Swaps Remaining Number of Interest Rate Swaps Remaining Number of Interest Rate Swaps Remaining Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Purchase of capped call related to convertible notes Purchase of capped call related to convertible notes Purchase Of Capped Call Related To Convertible Notes Purchase Of Capped Call Related To Convertible Notes Additional paid-in capital Additional Paid in Capital, Common Stock Compensation Amount Outstanding Recovery Compensation Amount Thereafter Long-Term Debt, Maturity, After Year Four Long-Term Debt, Maturity, After Year Four Diluted EPS Earnings Per Share, Diluted [Abstract] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Geographical [Axis] Geographical [Axis] Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Debt issuance costs Payments of Debt Issuance Costs Tabular List, Table Tabular List [Table Text Block] Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] Shares repurchased Stock Repurchased During Period, Value Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] 2024 Revised Credit Facilities 2024 Revised Credit Agreement [Member] 2024 Revised Credit Agreement Other long-term assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Anti-dilutive shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Gain on repurchase of convertible senior notes, net Gain (loss) on repurchase of debt instrument Gain (Loss) on Repurchase of Debt Instrument Accelerated share repurchases, initial price paid per share (in CAD per share) Accelerated Share Repurchases, Initial Price Paid Per Share Payments Payments for Restructuring Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents at End of Period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Current assets: Assets, Current [Abstract] Goodwill Goodwill, carrying amount, beginning balance Goodwill, carrying amount, ending balance Goodwill Consolidation Items [Axis] Consolidation Items [Axis] Beginning balance Ending balance Accounts Receivable, Allowance for Credit Loss Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Cash used to net share settle employee equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Share repurchase plan, authorized amount Share Repurchase Program, Authorized, Amount INVENTORIES Inventory Disclosure [Text Block] Adjustments to additional paid in capital, convertible debt, capped call purchases Adjustments to Additional Paid in Capital, Convertible Debt, Capped Call Purchases Adjustments to Additional Paid in Capital, Convertible Debt, Capped Call Purchases Customer contracts and related relationships Customer Contracts [Member] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Goodwill [Roll Forward] Goodwill [Roll Forward] Depreciation Depreciation Estimated Fair Value Assets (Liabilities) Derivative, Fair Value, Net Other financing activities Proceeds from (Payments for) Other Financing Activities Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Security Exchange Name Security Exchange Name Award Type Award Type [Axis] Selected Information by Business Segment Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Currency translation Goodwill, Foreign Currency Translation Gain (Loss) Basic EPS Earnings Per Share, Basic [Abstract] Deferred debt issuance cost, writeoff Deferred Debt Issuance Cost, Writeoff Whole Blood Whole Blood, Blood Center [Member] Whole Blood, Blood Center Work-in-process Inventory, Work in Process, Net of Reserves Property, plant and equipment, net Property, Plant and Equipment, Net Convertible notes Convertible Debt [Member] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Research and Development Expense Weighted-Average Amortization Period Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Revolving credit facility Revolving Credit Facility [Member] Expiration Date Trading Arrangement Expiration Date Cash Flows from Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Contingent Consideration Contingent Consideration [Member] Contingent Consideration Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Total Shareholder Return Amount Total Shareholder Return Amount Common stock, shares issued (in shares) Common Stock, Shares, Issued Other Assets Other Assets [Member] Risk-Adjusted Discount Rates used in Purchase Price Allocation Acquired Intangible Assets, Risk-Adjusted Discount Rate Acquired Intangible Assets, Risk-Adjusted Discount Rate Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Write-offs Accounts Receivable, Allowance For Credit Loss, Recovery (Writeoff) Accounts Receivable, Allowance For Credit Loss, Recovery (Writeoff) Discrete Income Tax Benefit (Expense) [Axis] Discrete Income Tax Benefit (Expense) [Axis] Discrete Income Tax Benefit (Expense) Hospital Hospital Products and Services [Member] Hospital Products and Services [Member] Convertible Senior Notes Due 2029 Convertible Senior Notes Due 2029 [Member] Convertible Senior Notes Due 2029 Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Effect of exchange rates Effect of Exchange Rates on Operating Income Effect of Exchange Rates on Operating Income Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Debt instrument, percent of principal amount due in year 4 Debt Instrument, Percent of Principal Amount Due In Year 4 Debt Instrument, Percent of Principal Amount Due In Year 4 Debt instrument, percent of principal amount due in year 5 Debt Instrument, Percent of Principal Amount Due In Year 5 Debt Instrument, Percent of Principal Amount Due In Year 5 Total Property, Plant and Equipment, Gross Exercise of stock options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Amount of Gain Recognized in Accumulated Other Comprehensive Loss Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Rest of Asia Asia [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Research and development Research and Development Expense [Member] Europe Europe [Member] Impairment of intangible assets Goodwill and Intangible Asset Impairment Common stock, shares authorized (in shares) Common Stock, Shares Authorized In-process software development In Process Software Development [Member] In Process Software Development [Member] Acquisition, net of cash acquired Payments to acquire businesses, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Diluted (in shares) Diluted weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Diluted Designated foreign currency hedge contracts outstanding Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net Expected cost Restructuring and Related Cost, Expected Cost Restructuring costs Restructuring Costs MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Remainder of Fiscal 2025 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Change in prepaid income taxes Increase (Decrease) in Prepaid Taxes Total stockholders’ equity Balance Balance Equity, Attributable to Parent Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Additional debt issuance costs capitalized Additional Debt Issuance Costs Capitalized Additional Debt Issuance Costs Capitalized Accelerated share repurchases, initial delivery percentage of notional amount (as a percent) Accelerated Share Repurchases, Initial Delivery Percentage Of Notional Amount Accelerated Share Repurchases, Initial Delivery Percentage Of Notional Amount Balance Sheet Location [Axis] Statement of Financial Position Location, Balance [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Plasma Plasma [Member] Plasma [Member] Deferred tax benefit Deferred Income Tax Expense (Benefit) Capped call transaction, anti-dilution adjustment (in shares) Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares Debt Instrument, Convertible, Capped Call Transaction, Anti-Dilution Adjustment, Shares Schedule of Goodwill Schedule of Goodwill [Table Text Block] PROPERTY, PLANT AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Selling, general and administrative Selling, General and Administrative Expense Fair Value, Recurring [Member] Fair Value, Recurring [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] 2020 Program 2020 Program [Member] 2020 Program [Member] Accounts receivable, less allowance for credit losses of $5,912 at September 28, 2024 and $5,695 at March 30, 2024 Accounts Receivable, after Allowance for Credit Loss, Current Debt instrument, convertible, conversion price Debt Instrument, Convertible, Conversion Price Cost of goods sold Cost of Sales [Member] Impairment of intangible assets Asset Impairment Charges Debt outstanding Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus Fiscal 2029 Long-Term Debt, Maturity, Year Four Legal and professional fees Business Combination, Acquisition Related Costs All Executive Categories All Executive Categories [Member] Vascular Closure, Hosptial Interventional Technologies, Hospital [Member] Interventional Technologies, Hospital Balance Sheet Location [Domain] Statement of Financial Position Location, Balance [Domain] Hospital Hospital [Member] Hospital [Member] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Fiscal 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] ASSETS Assets [Abstract] Other comprehensive income (loss) Net current period other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Document Type Document Type Derivative Contract [Domain] Derivative Contract [Domain] Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Capitalized software Computer Software, Intangible Asset [Member] Revenue-based payment Revenue-based payment [Member] Revenue-based payment Debt instrument, convertible, conversion rate Debt Instrument, Convertible, Conversion Rate Debt Instrument, Convertible, Conversion Rate Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Non-amortizable: Indefinite-Lived Intangible Assets (Excluding Goodwill) Other borrowings Bank loans and other borrowings [Member] Bank loans and other borrowings Maximum Maximum [Member] Aggregate amortization expense Amortization of Intangible Assets Contract liabilities Contract with Customer, Liability Term loan borrowings Proceeds From Issuance Of Long-Term Debt, Excluding Line Of Credit Proceeds From Issuance Of Long-Term Debt, Excluding Line Of Credit Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Net Finite-Lived Intangible Assets, Net Accounts payable Accounts Payable, Current Blood Center Blood Center [Member] Blood Center [Member] PCS2 related charges Impairment Of Assets And PCS2 Related Charges (Credits) Impairment Of Assets And PCS2 Related Charges (Credits) ACQUISITIONS AND STRATEGIC INVESTMENTS Business Combination Disclosure [Text Block] Term loan redemption Decrease For Redemption Of Long-Term Debt Decrease For Redemption Of Long-Term Debt Current Fiscal Year End Date Current Fiscal Year End Date Convertible Senior Notes Due 2026 Convertible Senior Notes Due 2026 [Member] Convertible Senior Notes Due 2026 Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount All Award Types Award Type [Domain] Name Outstanding Recovery, Individual Name Business combination, recognized identifiable assets acquired and liabilities assumed, cash and equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Deferred tax asset Deferred Income Tax Assets, Net Non-PEO NEO Non-PEO NEO [Member] Weighted average useful life Finite-Lived Intangible Asset, Useful Life Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Money market funds Investments, Fair Value Disclosure Additional Paid-in Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] MDR and IVDR costs European Medical Device Regulation Costs European Medical Device Regulation Costs Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Investment, Name [Axis] Investment, Name [Axis] Debt instrument, redemption price, percentage Debt Instrument, Redemption Price, Percentage Deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Customer contracts and related relationships Customer Relationships [Member] Diluted income (loss) per share (in dollars per share) Earnings Per Share, Diluted Deferred income tax expense (benefit) Deferred Tax Assets, Derivative Instruments Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Intangible assets, amortization Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Vivasure Medical LTD Vivasure Medical LTD [Member] Vivasure Medical LTD Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Debt instrument, redemption price, percentage of principal amount redeemed Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] RESTRUCTURING Restructuring and Related Activities Disclosure [Text Block] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Defined Benefit Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Provision for income taxes Income Tax Expense (Benefit) Stated rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Notional amount Derivative, Notional Amount Corporate Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Schedule of Investments [Line Items] Schedule of Investments [Line Items] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Net revenues Revenue from Contract with Customer, Excluding Assessed Tax Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments Derivative Instruments, Gain (Loss) [Table Text Block] Other Other Country or Region [Member] Other Country or Region [Member] Portfolio Rationalization Portfolio Rationalization [Member] Portfolio Rationalization Reported tax rate Effective Income Tax Rate Reconciliation, Percent Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating income Operating income Operating Income (Loss) Interest expense Interest Expense, Operating and Nonoperating Business Acquisition [Line Items] Business Acquisition [Line Items] Cumulative costs to date Restructuring and Related Cost, Cost Incurred to Date Number of reportable segments Number of Reportable Segments Total liabilities and stockholders’ equity Liabilities and Equity Other non-cash operating activities Other Operating Activities, Cash Flow Statement Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accrued payroll and related costs Employee-related Liabilities, Current Hedging Designation [Axis] Hedging Designation [Axis] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Costs incurred, net of reversals Restructuring costs Restructuring Charges Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Non-cash items: Non-Cash Items [Abstract] Non-Cash Items [Abstract] Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Individual: Individual [Axis] Building and building improvements Building and Building Improvements [Member] Tax withholding on employee equity awards Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Issuance of restricted stock, net of cancellations Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Accumulated Other Comprehensive (Loss)/Income AOCI Attributable to Parent [Member] Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Net Unrealized Gain (Loss) on Derivatives Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Inventories, net Inventories, net Inventory, Net Number of interest rate swaps entered Number Of Interest Rate Swaps Entered Number Of Interest Rate Swaps Entered Product and Service [Axis] Product and Service [Axis] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Capped call transaction, initial cap price (in dollars per share) Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price Debt Instrument, Convertible, Capped Call Transaction, Initial Cap Price Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Operating expenses: Operating Expenses [Abstract] Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Interest Rate Swap, 4.15% Fixed Interest Rate Interest Rate Swap, 4.15% Fixed Interest Rate [Member] Interest Rate Swap, 4.15% Fixed Interest Rate LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] DERIVATIVES AND FAIR VALUE MEASUREMENTS Derivatives and Fair Value [Text Block] Blood Center Blood Center Products and Services [Member] Blood Center Products and Services [Member] Loss contingency, estimate of possible loss Loss Contingency, Estimate of Possible Loss Restructuring and related cost, incurred cost Restructuring and Related Cost, Incurred Cost Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Derivative fixed interest rate Derivative, Fixed Interest Rate Share Repurchase Program [Line Items] Share Repurchase Program [Line Items] Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Accrued payroll and related costs Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll and Related Costs Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Payroll and Related Costs Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Credit loss Accounts Receivable, Credit Loss Expense (Reversal) Segments [Axis] Segments [Axis] Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Long-term debt, gross Long-Term Debt, Gross Exercise Price Award Exercise Price EARNINGS PER SHARE Earnings Per Share [Text Block] Office equipment and information technology Office Equipment and Information Technology [Member] Office Equipment and Information Technology Arrangement Duration Trading Arrangement Duration Event-based payment Event-based payment [Member] Event-based payment Employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Subsequent Event Subsequent Event [Member] Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Consolidated interest coverage ratio Consolidated Interest Coverage Ratio Consolidated Interest Coverage Ratio GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Gain (loss) on investments Gain (Loss) on Investments Investment Investments Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Restructuring Plan [Axis] Restructuring Plan [Axis] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] 2022 Revised Credit Facilities 2022 Revised Credit Agreement [Member] 2022 Revised Credit Agreement Regulatory-based payment Regulatory-based payment [Member] Regulatory-based payment Debt Instrument, Repurchase Amount Debt Instrument, Repurchase Amount Fiscal 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Four All Individuals All Individuals [Member] Total consideration Business Combination, Price of Acquisition, Expected Number Of Interest Rate Swaps Terminated Number Of Interest Rate Swaps Terminated Number Of Interest Rate Swaps Terminated PEO PEO [Member] Revised Credit Agreement Revised Credit Agreement [Member] Revised Credit Agreement Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Interest and other expense, net Other Nonoperating Income (Expense) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Intangible assets, less accumulated amortization of $484,517 at September 28, 2024 and $455,213 at March 30, 2024 Intangible Assets, Net (Excluding Goodwill) Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Remainder of Fiscal 2025 Long-Term Debt, Maturity, Remainder of Fiscal Year Revolving credit facility unused fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Assets Assets, Fair Value Disclosure [Abstract] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Consolidated total leverage ratio Consolidated Total Leverage Ratio Consolidated Total Leverage Ratio Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Integration and transaction costs Operating Expenses, Transaction Costs Operating Expenses, Transaction Costs Local Phone Number Local Phone Number Accelerated share repurchases, settlement (payment) or receipt Accelerated Share Repurchases, Settlement (Payment) or Receipt Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Interest Rate Swap, 4.08% Fixed Interest Rate Interest Rate Swap, 4.08% Fixed Interest Rate [Member] Interest Rate Swap, 4.08% Fixed Interest Rate Maturity period for foreign currency contracts Average Remaining Maturity of Foreign Currency Derivatives Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Total operating expenses Operating Expenses Schedule of Revenues by Business Unit and Geographic Regions Reconciliation of Revenue from Segments to Consolidated [Table Text Block] Deferred tax liability Deferred Income Tax Liabilities, Net 2024 Accelerated Share Repurchase Program 2024 Accelerated Share Repurchase Program [Member] 2024 Accelerated Share Repurchase Program Shares repurchased (in shares) Shares repurchased (in shares) Stock Repurchased During Period, Shares Change in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Acquired intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Derivative Liabilities Derivative Liability, Subject to Master Netting Arrangement, before Offset Apheresis Apheresis, Blood Center [Member] Apheresis, Blood Center Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Impairment of intangible assets Impairment of Intangible Assets, Finite-Lived COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Debt Instrument [Line Items] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Measure: Measure [Axis] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Uncommitted Operating Lines of Credit Line of Credit [Member] Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Liabilities fair value Liabilities, Fair Value Disclosure Segment Reporting [Abstract] Segment Reporting [Abstract] Tax withholding on employee equity awards (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Entity Central Index Key Entity Central Index Key Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Foreign Currency Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Corporate Corporate Segment [Member] ACCUMULATED OTHER COMPREHENSIVE LOSS Equity [Text Block] Change in accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] SEGMENT AND ENTERPRISE-WIDE INFORMATION Segment Reporting Disclosure [Text Block] Notes payable and current maturities of long-term debt Notes payable and current maturities of long-term debt Long-Term Debt, Current Maturities Japan JAPAN Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Text Block [Abstract] Amounts reclassified from Accumulated Other Comprehensive Income (Loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax RECENT ACCOUNTING PRONOUNCEMENTS Accounting Standards Update and Change in Accounting Principle [Text Block] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Loss in period Loss Contingency, Loss in Period Title Trading Arrangement, Individual Title Debt Instrument, Repurchased Face Amount Debt Instrument, Repurchased Face Amount Unsecured Debt Unsecured Debt [Member] Stock Compensation Windfalls Stock Compensation Windfalls [Member] Stock Compensation Windfalls Statement [Table] Statement [Table] Interest expense, debt Interest Expense, Debt Measurement Frequency [Domain] Measurement Frequency [Domain] Consolidation Items [Domain] Consolidation Items [Domain] City Area Code City Area Code Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Value At Acquisition Date Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Value At Acquisition Date Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Value At Acquisition Date Current liabilities: Liabilities, Current [Abstract] Contingent consideration Business Combination, Contingent Consideration, Liability Non-designated foreign currency hedge contracts outstanding Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Gain on sale of property, plant and equipment Gain (Loss) on Disposition of Assets Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Share repurchases Payments for Repurchase of Common Stock Fiscal 2028 Long-Term Debt, Maturity, Year Three Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Long-term debt Long-term debt Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Performance obligation percent Revenue, Remaining Performance Obligation, Percentage INCOME TAXES Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Developed technology Other Technology [Member] Other Technology [Member] Attune Medical Attune Medical [Member] Attune Medical Retained earnings Retained Earnings (Accumulated Deficit) Gain (loss) to be reclassified within the next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Debt instrument, percent of principal amount due in years 1-3 Debt Instrument, Percent of Principal Amount Due In Years 1-3 Debt Instrument, Percent of Principal Amount Due In Years 1-3 Change in inventories Increase (Decrease) in Inventories Payments on revolving facility Repayments of Long-Term Lines of Credit Debt issuance costs, gross Debt Issuance Costs, Gross Schedule of Debt Schedule of Debt [Table Text Block] Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Fiscal 2027 Long-Term Debt, Maturity, Year Two Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Percentage of sales generated outside the US Percentage Of Net Sales Generated Outside Of The US Percentage Of Net Sales Generated Outside Of The US Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustment Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustment Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustment Restructuring and Restructuring Related Costs Restructuring and Restructuring Related Costs Restructuring and Restructuring Related Costs Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Upfront payment Payments to Acquire Businesses, Gross Gains on sales of property, plant and equipment Sale of property Gain (Loss) on Disposition of Property Plant Equipment Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Gross profit Gross Profit Plant equipment and machinery Machinery and Equipment [Member] Fair Value as of Grant Date Award Grant Date Fair Value Other comprehensive income (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Discrete Income Tax Benefit (Expense) [Domain] Discrete Income Tax Benefit (Expense) [Domain] Discrete Income Tax Benefit (Expense) [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Debt issuance costs, net Debt Issuance Costs, Net NOTES PAYABLE AND LONG-TERM DEBT Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Geographical [Domain] Geographical [Domain] Customer-Related Intangible Assets Customer-Related Intangible Assets [Member] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Face amount of debt Debt Instrument, Face Amount Developed technology Technology-Based Intangible Assets [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Interest Rate Swap Interest Rate Swap [Member] Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Restatement Determination Date: Restatement Determination Date [Axis] Title of 12(b) Security Title of 12(b) Security Amortization of fair value inventory step-up Amortization of Fair Value Inventory Step Up Amortization of Fair Value Inventory Step Up Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 50,381,127 shares at September 28, 2024 and 50,787,859 shares at March 30, 2024 Common Stock, Value, Issued Digital transformation costs Digital Transformation Costs Digital Transformation Costs Haemonetics equipment Haemonetics Equipment [Member] Haemonetics Equipment Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Schedule of Investments [Table] Schedule of Investments [Table] Other Noncurrent Assets Other Noncurrent Assets [Member] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Other Current Liabilities Other Current Liabilities [Member] Cash Flows from Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Amortization of acquired intangible assets Amortization of Acquired Intangible Assets Amortization of Acquired Intangible Assets Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Basic income (loss) per share (in dollars per share) Earnings Per Share, Basic Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Schedule of Goodwill [Table] Goodwill [Table] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Amortizable: Finite-Lived Intangible Assets, Net [Abstract] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Total assets Assets Fiscal 2026 Finite-Lived Intangible Asset, Expected Amortization, Year One Cost of goods sold Cost of Goods and Services Sold Gain (loss) on extinguishment of debt, before debt issuance cost writeoff Gain (Loss) on Extinguishment of Debt, before Debt Issuance Cost Writeoff Capital expenditures Payments to Acquire Property, Plant, and Equipment Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Termination Date Trading Arrangement Termination Date Operating lease, revenue, as a percentage of total net sales Operating Lease, Revenue, As A Percentage Of Total Net Sales Operating Lease, Revenue, As A Percentage Of Total Net Sales Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fiscal 2026 Long-Term Debt, Maturity, Year One Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Proceeds from employee stock purchase plan Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP Entity Address, City or Town Entity Address, City or Town Debt Instrument [Axis] Debt Instrument [Axis] Convertible notes, fair value Convertible Debt, Fair Value Disclosures Net income Net income Net income Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Business combination, estimated working capital adjustment Business Combination, Working Capital Adjustment Business Combination, Working Capital Adjustment Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Contingent Consideration Fair Value, Risk-Adjusted Discount Rate Contingent Consideration Fair Value, Risk-Adjusted Discount Rate Contingent Consideration Fair Value, Risk-Adjusted Discount Rate Entity File Number Entity File Number Liabilities Liabilities, Fair Value Disclosure [Abstract] REVENUE Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Effect of exchange rates on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Assets fair value Assets, Fair Value Disclosure Restructuring Plan [Domain] Restructuring Plan [Domain] Name Forgone Recovery, Individual Name Document Period End Date Document Period End Date Schedule of Interest Rate Swaps Schedule of Interest Rate Derivatives [Table Text Block] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Finished goods Inventory, Finished Goods, Net of Reserves Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Insider Trading Arrangements [Line Items] Josep L. Llorens [Member] Josep L. Llorens Derivative, percentage of notional value of debt Derivative, Percentage Of Notional Value Of Debt Derivative, Percentage Of Notional Value Of Debt Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effect of exchange rates Effect of Exchange Rate on Revenues Effect of Exchange Rate on Revenues Other Current Assets Other Current Assets [Member] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Net revenues in constant currency Net Revenues, By Business Unit Before Foreign Exchange Impact Net Revenues, By Business Unit Before Foreign Exchange Impact Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Revenue recognized Contract with Customer, Liability, Revenue Recognized OpSens, Inc. OpSens, Inc. [Member] OpSens, Inc. Adjustment to Compensation: Adjustment to Compensation [Axis] Plasma Plasma Products and Services [Member] Plasma Products and Services [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Restructuring related costs Restructuring Related Costs Restructuring Related Costs Foreign Exchange Contract Foreign Exchange Contract [Member] Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Other investing activities Payments to Acquire Other Investments Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Accumulated other comprehensive loss Balance as of March 30, 2024 Balance as of September 28, 2024 Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Litigation-related charges Litigation Settlement, Fee Expense Hemostasis Management, Hospital Hemostasis Management, Hospital [Member] Hemostasis Management, Hospital Basic (in shares) Weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Term loan, net of financing fees Medium-Term Note [Member] Payment to acquire investment Payments to Acquire Investments Name Awards Close in Time to MNPI Disclosures, Individual Name Other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Construction in progress Construction in Progress [Member] Capped call transaction, initial strike price (in dollars per share) Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price Debt Instrument, Convertible, Capped Call Transaction, Initial Strike Price Entity Filer Category Entity Filer Category Amount of Gain Excluded from Effectiveness Testing Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net Restructuring liability Balance at March 30, 2024 Balance at September 28, 2024 Restructuring Reserve Balance (in shares) Balance (in shares) Shares, Issued Performance obligation amount Revenue, Remaining Performance Obligation, Amount Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Interest rate floor Debt Instrument, Interest Rate, Floor Debt Instrument, Interest Rate, Floor Company Selected Measure Name Company Selected Measure Name